Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N4WZ
|
|||
| Former ID |
DNC014550
|
|||
| Drug Name |
CGP-36216
|
|||
| Synonyms |
CGP-36216; CHEMBL325921; 123691-29-2; SCHEMBL2348729; RWCIPYZWXPUGRM-UHFFFAOYSA-N; ethyl(3-aminopropyl)phosphinic acid; 3-aminopropyl(ethyl)phosphinic acid; (3-aminopropyl)ethylphosphinic acid; ZINC13742894; PDSP1_000409; PDSP2_000407; ethyl-(3-aminopropyl)phosphinic acid; BDBM50032972; (3-Amino-propyl)-ethyl-phosphinic acid; Phosphinic acid, P-(3-aminopropyl)-P-ethyl-
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C5H14NO2P
|
|||
| Canonical SMILES |
CCP(=O)(CCCN)O
|
|||
| InChI |
1S/C5H14NO2P/c1-2-9(7,8)5-3-4-6/h2-6H2,1H3,(H,7,8)
|
|||
| InChIKey |
RWCIPYZWXPUGRM-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Gamma-aminobutyric acid B receptor (GABBR) | Target Info | Inhibitor | [1] |
| KEGG Pathway | cAMP signaling pathway | |||
| Neuroactive ligand-receptor interaction | ||||
| GABAergic synapse | ||||
| Estrogen signaling pathway | ||||
| Morphine addiction | ||||
| Reactome | Activation of G protein gated Potassium channels | |||
| G alpha (i) signalling events | ||||
| Class C/3 (Metabotropic glutamate/pheromone receptors) | ||||
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | ||||
| WikiPathways | GPCRs, Class C Metabotropic glutamate, pheromone | |||
| Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell | ||||
| Potassium Channels | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Biological activity of 3-aminopropyl (methyl) phosphinic acid, a potent and selective GABAB agonist with CNS activity, Bioorg. Med. Chem. Lett. 3(4):515-518 (1993). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.